| 2018

Alzheimer’s Risk is Higher in Women: Identification of Female-specific Brain Bioenergetic Targets

Amylyx, | 2019

PEGASUS Clinical Study of AMX0035 in Alzheimer’s Disease

Erin H. Norris, Sidney Strickland, | 2017

The Role of the Contact System in Alzheimer’s Disease

Subhash Sinha, | 2018

The Development of DNA-Encoded Libraries to Discover Therapeutically Valuable Low Molecular Weight Compounds for Alzheimer’s Disease

Lucía Chávez-Gutiérrez, William Mobley, | 2018

Amyloid Beta-Mediated Inhibition of Gamma-Secretase Activity Induces Alzheimer’s Disease-Relevant Cellular Phenotypes

Jaime Grutzendler, | 2018

The Neuroprotective Glial Barrier: A Multicellular Reaction with Therapeutic Potential in Alzheimer’s Disease

Benjamin M. Hampstead, Bruno Giordani, Henry Paulson, | 2018

Neurobiological Basis of Cognitive Impairment in African Americans: Deep Phenotyping of Older African Americans at Risk of Dementia

Filip Swirski, | 2018

Interleukin-3 in Alzheimer’s Disease

Darren J. Baker, | 2018

Senescent Cells and Alzheimer’s Disease

Roberto Malinow, | 2018

Pharmacologically Protecting and Rescuing Synapses from Beta Amyloid by Raising Synaptic PSD-95

Christiane Wrann, Se Hoon Choi, | 2018

Neuroprotective Effects of the Exercise Hormone Irisin in Alzheimer’s Disease

Brian P. Head, Steven Wagner, | 2018

The Effect of Chronic Gamma-Secretase Modulation on the Prevention of Traumatic Brain Injury-Provoked and Alzheimer’s Disease-Relevant Biochemical, Pathological and Behavioral Alterations